Resection or Transplant in Early Hepatocellular Carcinoma.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28835324)

Published in Dtsch Arztebl Int on August 07, 2017

Authors

Markus B Schoenberg1, Julian N Bucher, Adrian Vater, Alexandr V Bazhin, Jingcheng Hao, Markus O Guba, Martin K Angele, Jens Werner, Markus Rentsch

Author Affiliations

1: Markus B. Schoenberg and Julian N. Bucher shared first authorship; Department of General, Visceral and Transplantation Surgery, University Hospital of Munich, Campus Großhadern; Munich Transplant Center, University Hospital of Munich, Campus Großhadern; Liver Center Munich, University Hospital of Munich, Campus Großhadern.

Articles cited by this

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52

Hepatocellular carcinoma. N Engl J Med (2011) 19.40

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol (2012) 16.93

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology (1999) 5.70

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl (2006) 3.73

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12

Alcohol and hepatocellular carcinoma. Gastroenterology (2004) 2.61

Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch Arztebl Int (2014) 2.21

Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg (2012) 2.18

Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl (2005) 2.04

Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg (2003) 2.02

Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol (2006) 1.69

Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg (2011) 1.62

Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg (1998) 1.61

Changing management and outcome of hepatocellular carcinoma: evaluation of 501 patients treated at a single comprehensive center. J Surg Oncol (2008) 1.52

Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol (1997) 1.45

Non-alcoholic steatohepatitis and cancer. Clin Liver Dis (2007) 1.44

Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology (2016) 1.40

Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg (2007) 1.38

Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg (2003) 1.35

The diagnosis and treatment of hepatocellular carcinoma. Dtsch Arztebl Int (2014) 1.29

Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology (2012) 1.24

Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl (2003) 1.24

Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg (1995) 1.20

Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg (2011) 1.19

Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology (1998) 1.14

An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol (2007) 1.11

Surgical management of hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg (1999) 1.10

Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg (2008) 1.04

Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) (2009) 1.02

Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the United States: a plea for outcome-based and not volume-based referral guidelines. Arch Surg (2009) 1.00

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg (2014) 0.99

Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol (1996) 0.98

Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria. Am J Surg (2010) 0.95

Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg (2003) 0.93

Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated. Ann Surg (2016) 0.93

Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion. Hepatol Int (2011) 0.91

Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies. Transplantation (2014) 0.90

Long-term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria. Ann Surg Oncol (2011) 0.89

Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection. HPB (Oxford) (2014) 0.89

Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol (2012) 0.88

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma. Medicine (Baltimore) (2015) 0.88

Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl (2008) 0.88

Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution. Surgery (1998) 0.86

Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival. Hepatology (2015) 0.85

Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. J Surg Oncol (2013) 0.85

Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm. Dig Dis (2007) 0.85

Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transplant Proc (2007) 0.84

A Novel Prognostic Index in Patients With Hepatocellular Cancer Waiting for Liver Transplantation: Time-Radiological-response-Alpha-fetoprotein-INflammation (TRAIN) Score. Ann Surg (2016) 0.83

Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol (2002) 0.83

A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function. Hepatobiliary Pancreat Dis Int (2015) 0.82

Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria. Transpl Int (2014) 0.82

Is liver transplantation superior to resection in early stage hepatocellular carcinoma? Transplant Proc (1999) 0.81

Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver Int (2007) 0.81

Hepatic resection or orthotopic liver transplant in cirrhotic patients with small hepatocellular carcinoma. Transplant Proc (1995) 0.81

Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis. Ann Surg Oncol (2014) 0.81

Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy. Am J Clin Oncol (2011) 0.80

Liver transplantation versus liver resection for hepatocellular carcinoma: a meta-analysis. Hepatobiliary Pancreat Dis Int (2014) 0.80

The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma. Future Oncol (2014) 0.79

Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol (2013) 0.79

List and liver transplant survival according to waiting time in patients with hepatocellular carcinoma. Am J Transplant (2015) 0.78

The role of liver transplantation or resection for patients with early hepatocellular carcinoma. Tumour Biol (2015) 0.78

Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg (2014) 0.78

Hepatocellular carcinoma: surgical treatment and prognostic variables in 56 patients. Hepatogastroenterology (2000) 0.78

Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified? Langenbecks Arch Surg (2007) 0.77

Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation. Ann Transplant (2012) 0.77

Resection or transplant-listing for solitary hepatitis C-associated hepatocellular carcinoma: an intention-to-treat analysis. HPB (Oxford) (2012) 0.77

Comparison of liver resection and transplantation for Child-pugh A cirrhotic patient with very early hepatocellular carcinoma and portal hypertension. Pak J Med Sci (2014) 0.77

Short-term and long-term outcomes of surgical treatment for HCC within Milan criteria with cirrhotic portal hypertension. Hepatogastroenterology (2015) 0.77

Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Dis Markers (2015) 0.77

Multimodal treatment of hepatocellular carcinoma: an eastern European experience. Hepatogastroenterology (2010) 0.76

Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principle. Clin Transplant (2013) 0.76

Severity of cirrhosis should determine the operative modality for patients with early hepatocellular carcinoma and compensated liver function. Surgery (2015) 0.76

Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis. Transplant Proc (2008) 0.76

Surgical resection and transplantation for hepatocellular carcinoma. Cancer Treat Res (1994) 0.76

[Therapy of hepatocellular carcinoma before liver transplantation]. Chirurg (2013) 0.76

Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study. Medicine (Baltimore) (2016) 0.75

CyberKnife Radiosurgery - Value as an Adjunct to Surgical Treatment of HCC? Cureus (2016) 0.75

The importance of a multidisciplinary approach to hepatocellular carcinoma. J Multidiscip Healthc (2017) 0.75

Articles by these authors

Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg (2012) 7.26

IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology (2002) 3.48

Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res (2007) 2.71

Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg (2002) 2.46

Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med (2008) 2.18

Temporary intraoperative porto-caval shunt: useless or beneficial in piggy back liver transplantation? Transpl Int (2012) 2.17

Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14

Loss of liver transplant surgeons into alternate career paths. Transpl Int (2014) 2.04

Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg (2011) 2.02

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A (2011) 1.89

Chronic pancreatitis--definition, etiology, investigation and treatment. Dtsch Arztebl Int (2013) 1.82

CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol (2012) 1.76

European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis (2013) 1.75

Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy, and necrosis in pancreatitis. Gastroenterology (2009) 1.72

Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas (2011) 1.64

Improvement of surgical results for pancreatic cancer. Lancet Oncol (2013) 1.60

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59

Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg (2009) 1.54

Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas (2012) 1.53

Anaplastic pancreatic cancer: Presentation, surgical management, and outcome. Surgery (2010) 1.49

Tumor infiltrated hilar and mediastinal lymph nodes are an independent prognostic factor for decreased survival after pulmonary metastasectomy in patients with renal cell carcinoma. J Urol (2010) 1.49

MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol (2012) 1.43

Feasibility and effectiveness of a new algorithm in preventing hepatic artery thrombosis after liver transplantation. J Gastrointest Surg (2008) 1.41

Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann Surg (2002) 1.39

Stimulation of Central α2 Receptors Attenuates Experimental Necrotizing Pancreatitis. Pancreas (2016) 1.38

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36

Immunological effects of laparoscopic vs open colorectal surgery: a prospective clinical study. Arch Surg (2005) 1.35

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol (2012) 1.28

Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One (2012) 1.25

Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort. PLoS One (2012) 1.25

Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol (2012) 1.21

Postoperative pancreatic fistula. Surgeon (2010) 1.17

Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis (2009) 1.16

Complex fluids of poly(oxyethylene) monoalkyl ether nonionic surfactants. Chem Rev (2010) 1.15

Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Int J Cancer (2013) 1.15

MR imaging for diagnosing cysto-biliary fistulas in cystic echinococcosis. Eur J Radiol (2007) 1.11

Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications. Langenbecks Arch Surg (2009) 1.10

The intrinsic renal compartment syndrome: new perspectives in kidney transplantation. Transplantation (2010) 1.10

Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg (2010) 1.08

Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment. J Pathol (2012) 1.08

Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg (2011) 1.08

Surgical management of severe pancreatitis including sterile necrosis. J Hepatobiliary Pancreat Surg (2002) 1.06

Management of infection in acute pancreatitis. J Hepatobiliary Pancreat Surg (2002) 1.05

Stable biomimetic super-hydrophobic engineering materials. J Am Chem Soc (2005) 1.03

Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection. Radiat Oncol (2013) 1.03

Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg (2015) 1.02

Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Oncotarget (2014) 1.02

A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas (2014) 1.01

Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Int J Cancer (2014) 1.01

Reactive oxygen species in the immune system. Int Rev Immunol (2013) 1.01

Decrease in clinically relevant pancreatic fistula by coverage of the pancreatic remnant after distal pancreatectomy. Surgery (2012) 0.99

Radiologic versus endoscopic evaluation of the conduit after esophageal resection: a prospective, blinded, intraindividually controlled diagnostic study. Surg Endosc (2014) 0.99

Pancreatic cancer susceptibility loci and their role in survival. PLoS One (2011) 0.98

Fast-track rehabilitation in elective colorectal surgery patients: a prospective clinical and immunological single-centre study. ANZ J Surg (2007) 0.97

Resection of the intrapancreatic bile duct preserving the pancreas. J Hepatobiliary Pancreat Surg (2008) 0.97

Risk factors for surgical complications in distal pancreatectomy. Am J Surg (2010) 0.96

MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol (2011) 0.96

Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Oncotarget (2014) 0.96

Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer. Surgery (2012) 0.96

Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer. Int J Oncol (2011) 0.95

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95

Different immune responses to abdominal surgery in men and women. Langenbecks Arch Surg (2003) 0.95

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. J Virol (2014) 0.95

Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? Am J Surg (2011) 0.95

Multilayer vesicles and vesicle clusters formed by the fullerene-based surfactant C60(CH3)5K. J Colloid Interface Sci (2004) 0.95

Phase behavior and properties of reverse vesicles in salt-free catanionic surfactant mixtures. J Phys Chem B (2008) 0.94

Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg (2008) 0.94

Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients. Transpl Int (2013) 0.94

Visual object working memory function and clinical symptoms in schizophrenia. Schizophr Res (2003) 0.93

Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis. BMC Cancer (2012) 0.93

The cooperativity between hydrogen and halogen bond in the XY···HNC···XY (X, Y = F, Cl, Br) complexes. J Mol Model (2011) 0.93

Pylorus resection in partial pancreaticoduodenectomy: impact on delayed gastric emptying. Am J Surg (2013) 0.92

Stable porphyrin vesicles formed in non-aqueous media and dried to produce hollow shells. Chem Commun (Camb) (2009) 0.92

Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: initial results. World J Gastroenterol (2009) 0.92

Gold-ionic liquid nanofluids with preferably tribological properties and thermal conductivity. Nanoscale Res Lett (2011) 0.92

Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg (2015) 0.92

Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy. Cancer Immunol Immunother (2013) 0.92

Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell Metab (2011) 0.92

Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. Dis Colon Rectum (2015) 0.91

Survival data justifies resection for pancreatic metastases. Ann Surg Oncol (2009) 0.91

Ischemic acute pancreatitis: clinical features of 11 patients and review of the literature. Am J Surg (2008) 0.91

Uncinate process first--a novel approach for pancreatic head resection. Langenbecks Arch Surg (2010) 0.91

Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg (2014) 0.91

Surgical therapy of chronic pancreatitis: indications, techniques and results. Int J Surg (2009) 0.90

Preservation of splenic immune functions by female sex hormones after trauma-hemorrhage. Crit Care Med (2002) 0.90

SEREX identification of new tumor antigens linked to melanoma-associated retinopathy. Int J Cancer (2005) 0.90

Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis. Crit Care (2008) 0.90

Reversibly switchable wettability. Chem Soc Rev (2009) 0.90

Caspase 3 inhibition improves survival and reduces early graft injury after ischemia and reperfusion in rat liver transplantation. Transplantation (2004) 0.90

Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery (2012) 0.90

Detrimental immunologic effects of preoperative chemoradiotherapy in advanced rectal cancer. Dis Colon Rectum (2003) 0.89

R0 in pancreatic cancer surgery: surgery, pathology, biology, or definition matters? Ann Surg (2010) 0.89

Estradiol inhibits chondrogenic differentiation of mesenchymal stem cells via nonclassic signaling. Arthritis Rheum (2010) 0.88

Carbon nanotubes incorporated within lyotropic hexagonal liquid crystal formed in room-temperature ionic liquids. Langmuir (2007) 0.88

Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy. Lung Cancer (2003) 0.88

Acute pancreatitis with an emphasis on infection. Infect Dis Clin North Am (2010) 0.88